Jenkins H et al. |
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study. |
2017 |
Clin Drug Investig |
pmid:27928738
|
Alba C et al. |
Antibiotic resistance in Helicobacter pylori. |
2017 |
Curr. Opin. Infect. Dis. |
pmid:28704226
|
Mishima E et al. |
Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole. |
2017 |
Intern. Med. |
pmid:28674358
|
Sun W et al. |
Synergistic drug combination effectively blocks Ebola virus infection. |
2017 |
Antiviral Res. |
pmid:27890675
|
Shimoyama T et al. |
Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens. |
2017 |
Intern. Med. |
pmid:28674348
|
Hung IFN et al. |
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial. |
2017 |
Chest |
pmid:27884765
|
Ustundag GH et al. |
The Effects of Synbiotic " B94 plus Inulin" Addition on Standard Triple Therapy of Eradication in Children. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28656129
|
Peng X et al. |
Gastric Juice-Based Real-Time PCR for Tailored Treatment: A Practical Approach. |
2017 |
Int J Med Sci |
pmid:28638276
|
Ozturk O et al. |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication. |
2017 |
Arab J Gastroenterol |
pmid:28601610
|
Aguilera-Correa JJ et al. |
Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. |
2017 |
Diagn. Microbiol. Infect. Dis. |
pmid:27863951
|
Alirezaei A et al. |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients. |
2017 |
Iran J Kidney Dis |
pmid:28575885
|
Katayama Y et al. |
Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation. |
2017 |
Life Sci. |
pmid:27825902
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Moj D et al. |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. |
2017 |
AAPS J |
pmid:27822600
|
Angol DC et al. |
from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. |
2017 |
Biomed Res Int |
pmid:28555193
|
Akpinar Z et al. |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. |
2017 |
Arab J Gastroenterol |
pmid:28532623
|
Beckman E et al. |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. |
2017 |
J. Clin. Microbiol. |
pmid:28515219
|
Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Yan J et al. |
Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital. |
2017 |
Eur Arch Otorhinolaryngol |
pmid:28508178
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Ivanová L et al. |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka. |
2017 |
Environ. Res. |
pmid:28183039
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Varma MV et al. |
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. |
2017 |
Clin. Pharmacol. Ther. |
pmid:27648490
|
Huet D et al. |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. |
2017 |
Rev Mal Respir |
pmid:27639948
|
El Haj C et al. |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? |
2017 |
Med. Microbiol. Immunol. |
pmid:27639707
|
Jia L et al. |
Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28711353
|
Seyama S et al. |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). |
2017 |
J. Antimicrob. Chemother. |
pmid:27999037
|
Zerbetto De Palma G et al. |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City. |
2017 |
Microb. Drug Resist. |
pmid:27391421
|
Giguère S |
Treatment of Infections Caused by Rhodococcus equi. |
2017 |
Vet. Clin. North Am. Equine Pract. |
pmid:28161038
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Legendre T et al. |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy]. |
2017 |
Encephale |
pmid:27178256
|
Choi HS et al. |
Peritoneal Dialysis-Related Peritonitis Caused by Microbacterium paraoxydans. |
2017 |
Jpn. J. Infect. Dis. |
pmid:27169951
|
Serrano CA et al. |
Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. |
2017 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:27159208
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Lee MC et al. |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. |
2017 |
J. Antimicrob. Chemother. |
pmid:29091186
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Laidler N |
Cutaneous infection with paucibacillary treated successfully with a modified antituberculous drug regimen. |
2017 |
BMJ Case Rep |
pmid:29275384
|
Lee JS et al. |
Implication of species change of Nontuberculous Mycobacteria during or after treatment. |
2017 |
BMC Pulm Med |
pmid:29262802
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Pastukh N et al. |
GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones. |
2017 |
Helicobacter |
pmid:29058343
|
Tognetti L et al. |
Bullous impetigo during interstitial pneumonitis. |
2017 |
G Ital Dermatol Venereol |
pmid:29050448
|
Chen MJ et al. |
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961996
|
Kim SY et al. |
Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. |
2017 |
Helicobacter |
pmid:28940815
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Oh ES et al. |
Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers. |
2017 |
J Clin Pharm Ther |
pmid:28806472
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Souto Filho JTD et al. |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection. |
2017 |
Ann. Hematol. |
pmid:28315923
|
Antonakos N et al. |
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome. |
2017 |
Crit Care |
pmid:28274246
|
Koratala A et al. |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement. |
2017 |
Blood Purif. |
pmid:28268216
|
Lin CM et al. |
Is ionizing radiation a risk factor to diffuse panbronchiolitis? |
2017 |
QJM |
pmid:28069906
|
Zhang D et al. |
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. |
2017 |
Medicine (Baltimore) |
pmid:28796053
|
Fraser AG |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776748
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
Makihara K et al. |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. |
2017 |
Cancer Chemother. Pharmacol. |
pmid:28711984
|
Tanabe H et al. |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. |
2017 |
Dig. Dis. Sci. |
pmid:28664410
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Sue S et al. |
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication. |
2017 |
Intern. Med. |
pmid:28566587
|
Hu Y et al. |
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance. |
2017 |
Front Cell Infect Microbiol |
pmid:28529929
|
Jeong SH et al. |
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. |
2017 |
Int. J. Infect. Dis. |
pmid:28522316
|
Kishida D et al. |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. |
2017 |
Intern. Med. |
pmid:28502947
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Komiya K et al. |
Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. |
2017 |
Respir. Res. |
pmid:28219384
|
Sakurai K et al. |
Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy. |
2017 |
World J. Gastroenterol. |
pmid:28216974
|
Awan S et al. |
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study. |
2017 |
Lung Cancer |
pmid:28213005
|
Su J et al. |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial. |
2017 |
Medicine (Baltimore) |
pmid:28207505
|
Branquinho D et al. |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? |
2017 |
BMC Gastroenterol |
pmid:28202013
|
Inukai K et al. |
Effect of gel formation on the dissolution behavior of clarithromycin tablets. |
2017 |
Int J Pharm |
pmid:28196716
|
Miftahussurur M et al. |
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic. |
2017 |
Am. J. Trop. Med. Hyg. |
pmid:28193745
|
Zhang Z et al. |
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Int. J. Antimicrob. Agents |
pmid:28188830
|
Kristin F et al. |
Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin. |
2017 |
Eur J Pharm Sci |
pmid:28179133
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Nagashima A et al. |
Clarithromycin Suppresses Chloride Channel Accessory 1 and Inhibits Interleukin-13-Induced Goblet Cell Hyperplasia in Human Bronchial Epithelial Cells. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27550358
|
Couture G et al. |
[Second case of serum sickness-like reaction to claritrhomycin]. |
2016 |
Presse Med |
pmid:27542759
|
Bugli F et al. |
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. |
2016 |
Biotechnol. Prog. |
pmid:27535356
|
Abd-Elsalam S et al. |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience. |
2016 |
Medicine (Baltimore) |
pmid:27310977
|
De Francesco V et al. |
Two-week Triple Therapy with either Standard or High-dose Esomeprazole for First-line H. pylori Eradication. |
2016 |
J Gastrointestin Liver Dis |
pmid:27308644
|
Miyaki A et al. |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility. |
2016 |
Minerva Gastroenterol Dietol |
pmid:27304198
|
Kim JS et al. |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. |
2016 |
Gut Liver |
pmid:27114421
|
Manniello MD et al. |
Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt. |
2016 |
Eur J Pharm Biopharm |
pmid:27106605
|
Fallone CA et al. |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. |
2016 |
Gastroenterology |
pmid:27102658
|
Bilgilier C et al. |
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients. |
2016 |
Ann. Hematol. |
pmid:27091350
|
Park JY et al. |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. |
2016 |
Dig. Dis. Sci. |
pmid:26923948
|
Guirao-Arrabal E et al. |
Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci. |
2016 |
Rev Esp Quimioter |
pmid:26888341
|
Trac MH et al. |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. |
2016 |
CMAJ |
pmid:26903359
|
Mukai S et al. |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. |
2016 |
Int. J. Oncol. |
pmid:26718641
|
Hirama T et al. |
PCR-Based Rapid Identification System Using Bridged Nucleic Acids for Detection of Clarithromycin-Resistant Mycobacterium avium-M. intracellulare Complex Isolates. |
2016 |
J. Clin. Microbiol. |
pmid:26739154
|
Radheshi E et al. |
Postmortem diagnosis of anaphylaxis in presence of decompositional changes. |
2016 |
J Forensic Leg Med |
pmid:26735898
|
Hassan ST et al. |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates. |
2016 |
Pharm Biol |
pmid:26731378
|
Hollitt A et al. |
Cat scratch disease of the parotid gland. |
2016 |
Arch. Dis. Child. |
pmid:26403943
|
Oh B et al. |
The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial. |
2016 |
Helicobacter |
pmid:26395781
|